有核红细胞提示烧伤患者死亡与并发症风险增加
有核红细胞阳性者死亡率比值比为6.0(P=.001;
要点
- 有核红细胞阳性与烧伤患者死亡率增加约6倍相关。
- 有核红细胞阳性者住院时间更长、损伤严重度评分更高且并发症更多。
- 即使低浓度有核红细胞也提示不良预后,可辅助死亡风险预测。
核心结论
- 有核红细胞存在与严重烧伤患者死亡率增加、住院时间延长、损伤严重度评分升高及并发症相关。
主要发现
- 有核红细胞更常见于老年患者(P<.001)。
- 有核红细胞阳性与住院时间延长(P<.001)、损伤严重度评分升高(P<.001)及并发症相关。
临床怎么用
- 对严重烧伤患者可关注有核红细胞检测结果,作为死亡风险增高的提示指标。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Nucleated red blood cells (NRBCs) have been studied in critically ill and injured patients as a predictor of increased in-hospital mortality and poor clinical outcomes. While prior studies have demonstrated the prognostic power of NRBCs in the critical patient, there has been a paucity of literature available describing their value as a prognostic indicator in the severely burned patient. This retrospective observational study was conducted from 2012 to 2017. Inclusion criteria for this study included all burn patients with total body surface area > 10% who were aged ≥ 15 years. Demographic and clinical data were collected from the electronic medical record system. Data analysis consisted of descriptive and comparative analysis using SPSS. Two hundred and nineteen patients (17.5%) met inclusion criteria with 51 (23.3%) patients positive for NRBCs. The presence of NRBCs had an increased mortality rate with an odds ratio of 6.0 (P = .001; 2.5, 14.5); was more likely to appear in older patients (P < .001); and was associated with increased hospital length of stay (P < .001), injury severity scores (P < .001), and complications. The presence of NRBCs even at the low concentrations reported in our study showed a 6-fold increase in the rate of mortality. With the current improvements in burn care leading to higher survival rates, the need to improve upon the numerous models that have been developed to predict mortality in severe burn patients is clear given the significantly increased risk of death that the presence of NRBCs portends.
引用
- Jenkins PM, Al Daoud F, Mercer L, et al. The Presence of Nucleated Red Blood Cells as an Indicator for Increased Mortality and Morbidity in Burn Patients. J Burn Care Res. 2021. PMID: 33608722. doi:10.1093/jbcr/irab035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。